ACT Brief: Who Sets Trial Endpoints, Human-Centered Trial Execution, and Bladder Cancer Approval Expansion - Applied Clinical Trials | Lyssna här | Poddtoppen.se
Fler avsnitt av ACT Brief: Who Sets Trial Endpoints, Human-Centered Trial Execution, and Bladder Cancer Approval Expansion
ACT Brief: Orchestrated AI Clinical Environments, eSource Coordinator Satisfaction, and Faster Clinical Trials Act
2026-10-23 |
1 min
+
ACT Brief: Applied Clinical Trials at 2026 SCRS Global Site Solutions Summit
2026-10-22 |
1 min
+
ACT Brief: AI Operating Models, Oncology Evidence Trust, and Thyroid Eye Disease Approval
2026-10-19 |
1 min
+
ACT Brief: Who Sets Trial Endpoints, Human-Centered Trial Execution, and Bladder Cancer Approval Expansion
2026-10-16 |
1 min
+
The Human Side of Clinical Trials: Why Fuzzy Mental Models Undermine Clinical Trial Execution
2026-10-15 |
39 min
+
ACT Brief: EHR-to-EDC Connectivity, FDA’s Rare Disease Framework, and Barriers to Oncology RWE
2026-10-15 |
1 min
+
ACT Brief: Design Drivers of Trial Representation, eSource-to-EDC Data Automation, and Roche's ALK7 Obesity License
2026-10-14 |
1 min
+
AI and Patient Recruitment: Can Predictive Promise Drive True Transformation?
2026-10-09 |
27 min
+
ACT Brief: RBQM Analysis Frequency, Building Trust in Oncology Data, and Rare Pediatric PRV Monetization
2026-10-09 |
1 min
+
ACT Brief: AI and Protocol Design, Site Training Readiness, and GLP-1 Unmet Needs
2026-10-08 |
1 min
+
Podden och tillhörande omslagsbild på den här sidan tillhör
Applied Clinical Trials. Innehållet i podden är skapat av Applied Clinical Trials och inte av,
eller tillsammans med, Poddtoppen.
En ny version av sidan finns tillgänglig.
Ladda om
Stäng
